According to Pulmatrix's latest financial reports the company's current earnings (TTM) are -$14.13 M. In 2022 the company made an earning of -$18.84 M an increase over its 2021 earnings that were of -$20.18 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$14.13 M | -25.03% |
2022 | -$18.84 M | -6.62% |
2021 | -$20.18 M | 4.47% |
2020 | -$19.31 M | -6.25% |
2019 | -$20.6 M | 0.16% |
2018 | -$20.57 M | 13.88% |
2017 | -$18.06 M | -41.38% |
2016 | -$30.81 M | 18.84% |
2015 | -$25.92 M | 323.1% |
2014 | -$6.13 M | 136.89% |
2013 | -$2.59 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pieris Pharmaceuticals PIRS | -$28.07 M | 98.72% | ๐บ๐ธ USA |
OPKO Health
OPK | -$0.19 B | 1,205.28% | ๐บ๐ธ USA |
Blueprint Medicines
BPMC | -$0.51 B | 3,483.41% | ๐บ๐ธ USA |